CoChat

Current clinical use of polygenic scores will risk exacerbating health disparities

Open access

Preprint — published as 10.1038/s41588-019-0379-x · Paper page

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Abstract

Polygenic risk scores (PRS) are poised to improve biomedical outcomes via precision medicine. However, the major ethical and scientific challenge surrounding clinical implementation is that they are many-fold more accurate in European ancestry individuals than others. This disparity is an inescapable consequence of Eurocentric genome-wide association study biases. This highlights that—unlike clinical biomarkers and prescription drugs, which may individually work better in some populations but do not ubiquitously perform far better in European populations—clinical uses of PRS today would systematically afford greater improvement to European descent populations. Early diversifying efforts show promise in levelling this vast imbalance, even when non-European sample sizes are considerably smaller than the largest studies to date. To realize the full and equitable potential of PRS, we must prioritize greater diversity in genetic studies and public dissemination of summary statistics to ensure that health disparities are not increased for those already most underserved.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/441261

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY · From the PDF
Figure 2 Demographic relationships, allele frequency differences, and local LD patterns between population pairs. Data analyzed from 1000 Genomes, in which population labels are: AFR = continental African, EUR = European, and EAS = East Asian. a ) Cartoon relationships among AFR, EUR, and EAS populations. b ) Allele frequency distributions in AFR, EUR, and EAS populations of variants from the GWAS catalog. c-e ) Color axis shows LD scale ( r 2 ). LD comparisons between pairs of populations show the same region of the genome for each comparison (representative region is chr1, 51572kb-52857kb) among pairs of SNPs polymorphic in both populations, illustrating that different SNPs are polymorphic across some population pairs, and that these SNPs have variable LD patterns across populations.
Figure 2 Demographic relationships, allele frequency differences, and local LD patterns between population pairs. Data analyzed from 1000 Genomes, in which population labels are: AFR = continental African, EUR = European, and EAS = East Asian. a ) Cartoon relationships among AFR, EUR, and EAS populations. b ) Allele frequency distributions in AFR, EUR, and EAS populations of variants from the GWAS catalog. c-e ) Color axis shows LD scale ( r 2 ). LD comparisons between pairs of populations show the same region of the genome for each comparison (representative region is chr1, 51572kb-52857kb) among pairs of SNPs polymorphic in both populations, illustrating that different SNPs are polymorphic across some population pairs, and that these SNPs have variable LD patterns across populations.CC-BY · From the PDF
Figure 3 Prediction accuracy relative to European ancestry individuals across 17 quantitative traits and 5 continental populations in UKBB . All phenotypes shown here are quantitative anthropometric and blood panel traits, as described in Supplementary Table 6 , which includes discovery cohort sample sizes. Prediction target individuals do not overlap with the discovery cohort and are unrelated, with sample sizes shown in Supplementary Table 7 . Violin plots show distributions of relative prediction accuracies, points show mean values, and error bars show standard errors of the means. Prediction R 2 for each trait and population are shown in Supplementary Figure 12 .
Figure 3 Prediction accuracy relative to European ancestry individuals across 17 quantitative traits and 5 continental populations in UKBB . All phenotypes shown here are quantitative anthropometric and blood panel traits, as described in Supplementary Table 6 , which includes discovery cohort sample sizes. Prediction target individuals do not overlap with the discovery cohort and are unrelated, with sample sizes shown in Supplementary Table 7 . Violin plots show distributions of relative prediction accuracies, points show mean values, and error bars show standard errors of the means. Prediction R 2 for each trait and population are shown in Supplementary Figure 12 .CC-BY · From the PDF
Figure 4 Polygenic risk prediction accuracy in Japanese, British, and African descent individuals using independent GWAS of equal sample sizes in the BioBank Japan (BBJ) and UK Biobank (UKBB). a ) Explanatory diagram showing the different discovery and target cohorts/populations, and disease endpoints versus quantitative traits. b-f ) Genetic prediction accuracy computed from independent BBJ and UKBB summary statistics with identical sample sizes ( Supplementary Tables 6 and 8 ). Note that y-axes differ, reflecting differences in prediction accuracy. b-c ) PRS accuracy for five diseases in: Japanese individuals in the BBJ ( b ) and British individuals in the UKBB. d-f ) PRS accuracy for 17 anthropometric and blood panel traits in: Japanese individuals in the BBJ ( d ), British individuals in the UKBB ( e ), and African descent British individuals in the UKBB ( f ). Trait abbreviations are as in Supplementary Table 6 . Each point shows the maximum R 2 (i.e. best predictor) across five p-value thresholds, and lines correspond to 95% confidence intervals calculated via bootstrap.
Figure 4 Polygenic risk prediction accuracy in Japanese, British, and African descent individuals using independent GWAS of equal sample sizes in the BioBank Japan (BBJ) and UK Biobank (UKBB). a ) Explanatory diagram showing the different discovery and target cohorts/populations, and disease endpoints versus quantitative traits. b-f ) Genetic prediction accuracy computed from independent BBJ and UKBB summary statistics with identical sample sizes ( Supplementary Tables 6 and 8 ). Note that y-axes differ, reflecting differences in prediction accuracy. b-c ) PRS accuracy for five diseases in: Japanese individuals in the BBJ ( b ) and British individuals in the UKBB. d-f ) PRS accuracy for 17 anthropometric and blood panel traits in: Japanese individuals in the BBJ ( d ), British individuals in the UKBB ( e ), and African descent British individuals in the UKBB ( f ). Trait abbreviations are as in Supplementary Table 6 . Each point shows the maximum R 2 (i.e. best predictor) across five p-value thresholds, and lines correspond to 95% confidence intervals calculated via bootstrap.CC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 85 references

Cited by

See all 2,813

Metadata

Authors
Martin, A. R., Kanai, M., Kamatani, Y., Okada, Y., Neale, B. M., & Daly, M. J.
Affiliations
  • Broad Institute (US)
  • Kyoto University (JP)
  • RIKEN Center for Integrative Medical Sciences (JP)
Corresponding author
Martin, Alicia R.
Venue
Nature Genetics
Publisher
openRxiv
Published
2018-10-11
Volume
51
Issue
4
Pages
584-591
ISSN
1061-4036 (ISSN-L)
OpenAlex
W2932671560
Cited by
2,813
References
77
Citations by year
2026: 446 · 2025: 412 · 2024: 385 · 2023: 445 · 2022: 408 · 2021: 390 · 2020: 227 · 2019: 93 · 2018: 3
FWCI
37.52
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Nature Genetics (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Japan Agency for Medical Research and Development
  • Masason Foundation
  • Ministry of Education, Culture, Sports, Science and Technology
  • National Institutes of Health (31063)
  • National Institute of Mental Health (K99MH117229)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK043351)
Topics
  • Social Sciences › Anthropology › Race, Genetics, and Society
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Forensic and Genetic Research
Keywords
polygenic risk score, health disparities, ancestry bias, genome-wide association study, precision medicine, underrepresented groups
MeSH terms
Genotype, Humans, Risk Factors, Genetic Predisposition to Disease, Multifactorial Inheritance, White People, Healthcare Disparities, Genome-Wide Association Study, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Current clinical use of polygenic scores will risk exacerbating health disparities. https://app.cochat.ai/papers/10.1101/441261
The paper
Martin, A. R., Kanai, M., Kamatani, Y., Okada, Y., Neale, B. M., & Daly, M. J. (2018). Current clinical use of polygenic scores will risk exacerbating health disparities. Nature Genetics. https://doi.org/10.1101/441261

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.